Biophytis Financials

Based on the key indicators related to Biophytis' liquidity, profitability, solvency, and operating efficiency, Biophytis is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.
  
Understanding current and past Biophytis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biophytis' financial statements are interrelated, with each one affecting the others. For example, an increase in Biophytis' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Biophytis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biophytis. Check Biophytis' Beneish M Score to see the likelihood of Biophytis' management manipulating its earnings.

Biophytis Stock Summary

Biophytis competes with Palatin Technologies, and Q32 Bio. Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was incorporated in 2006 and is headquartered in Paris, France. Biophytis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS09076G1040
Business AddressSorbonne University, Paris,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.biophytis.com
Phone33 1 44 27 23 00
CurrencyUSD - US Dollar

Biophytis Key Financial Ratios

Biophytis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Biophytis's current stock value. Our valuation model uses many indicators to compare Biophytis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biophytis competition to find correlations between indicators driving Biophytis's intrinsic value. More Info.
Biophytis is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Biophytis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Biophytis Stock

If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Valuation
Check real value of public entities based on technical and fundamental data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA